The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3

IMR Press is a leading publisher of open access peer-reviewed biomedical and life sciences journals. We aim to facilitate the dissemination of high-quality research in the area of biomedical science. With a long tradition and wide readership, IMR Press is dedicated to making positive contributions to academics, corporate libraries as well as to readers and authors. All the editors in IMR Press will provide the best service for researchers, allowing them to have a easy and smooth publication experience and helping maximize the impact and visibility of their research.

Exercise intolerance in kidney diseases: physiological

Cardiorenal syndrome type 1 and cardiorenal syndrome type 3. (a

Frontiers Cardiovascular-renal protective effect and molecular

Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis

Reno- and cardioprotective molecular mechanisms of SGLT2

Frontiers Biomarkers in Cardiorenal Syndrome and Potential

Cardiorenal syndrome: Multi‐organ dysfunction involving the heart

Cardiorenal protection of SGLT2 inhibitors—Perspectives from

Cardiorenal syndrome: long road between kidney and heart

Frontiers Immunomodulatory Approaches in Diabetes-Induced

Cells, Free Full-Text

JCM, Free Full-Text

The Molecular Mechanism and Therapeutic Strategy of Cardiorenal